Long-Term Transcriptomic Analysis of NRG/RTOG 9601: A Phase 3 Study of Salvage Radiotherapy for Prostate Cancer with or without Anti-Androgen Therapy
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S146-S147
DOI: 10.1016/j.ijrobp.2026.06.227 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von K. Patel und 19 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Patel, K., Feng, E., Walker, E., Proudfoot, J., Davicioni, E., Simko, J., Sandler, H., Pollack, A., Efstathiou, J., Dicker, A., Spratt, D., Bahary, J., Lukka, H., Hall, W., Stish, B., Shi, W., Pennington, J., Pugh, S., Nguyen, P., & Tran, P. (2026). Long-Term Transcriptomic Analysis of NRG/RTOG 9601: A Phase 3 Study of Salvage Radiotherapy for Prostate Cancer with or without Anti-Androgen Therapy. International Journal of Radiation Oncology*Biology*Physics, 126(1), S146-S147. https://doi.org/10.1016/j.ijrobp.2026.06.227
Vancouver
Patel K, Feng E, Walker E, Proudfoot J, Davicioni E, Simko J, et al. Long-Term Transcriptomic Analysis of NRG/RTOG 9601: A Phase 3 Study of Salvage Radiotherapy for Prostate Cancer with or without Anti-Androgen Therapy. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S146-S147. doi:10.1016/j.ijrobp.2026.06.227
BibTeX
@article{Patel2026,
author = {Patel, K. and Feng, E. and Walker, E. and Proudfoot, J. and Davicioni, E. and Simko, J. and Sandler, H.M. and Pollack, A. and Efstathiou, J.A. and Dicker, A.P. and Spratt, D.E. and Bahary, J.P. and Lukka, H. and Hall, W.A. and Stish, B.J. and Shi, W. and Pennington, J.D. and Pugh, S. and Nguyen, P.L. and Tran, P.T.},
title = {Long-Term Transcriptomic Analysis of NRG/RTOG 9601: A Phase 3 Study of Salvage Radiotherapy for Prostate Cancer with or without Anti-Androgen Therapy},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S146--S147},
doi = {10.1016/j.ijrobp.2026.06.227}
}
EUVIMED